Comparing intrathecal morphine and continuous wound infiltration for pain relief after pancreatic surgery
Official title: Effect of Single-Shot Intrathecal Morphine Injection Versus Continuous Wound Infiltration on Postoperative Pain After Pancreaticoduodenectomy: a Prospective, Open-Label, Randomized Controlled, Non-Inferiority Trial
Run by Seoul National University Hospital · NCT06761989 · Data updated 2026-11-12
This study is testing whether a single injection of morphine into the spine can help manage pain better than a continuous pain relief method after pancreatic surgery for adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul, Seoul) |
| Status | Recruiting |
| Started | January 15, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | January 7, 2027 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06761989 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 19 and older scheduled for elective open pancreaticoduodenectomy with a performance status of 0 or 1.
✕Probably not a fit
Patients with hypersensitivity to pain control medications or those with cognitive impairments affecting their ability to use pain management devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial is a prospective randomized open-label noninferiority comparison of intrathecal morphine injection versus continuous wound infiltration for pain management following open pancreaticoduodenectomy. The study aims to evaluate the effectiveness of these two analgesic methods, particularly focusing on their ability to manage severe postoperative pain resulting from the surgical procedure. Intrathecal morphine is hypothesized to provide potent, long-lasting pain relief with a single injection, while continuous wound infiltration requires catheter placement and may not effectively address visceral pain. The trial will enroll adults scheduled for elective pancreatic surgery and assess their pain management outcomes postoperatively.
Why it matters
Potential benefit: If successful, this study could provide a more effective and convenient pain management option for patients undergoing pancreatic surgery.
How similar studies have gone: Previous studies have shown that intrathecal morphine can provide effective analgesia, but this specific comparison with continuous wound infiltration has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 19 years of age or older * Scheduled for elective open pancreaticoduodenectomy or pylorus preseriving pancreaticoduodenectomy * Disease of periampullary lesions * Perfromance status assessed with ECOG score is 0 or 1 at the time of enrollment * Able to provide written informed consent to participate in the study, understand the procedures of this study, and complete patient-reported questionnaires * American Society of Anesthesiologists physical status I to III Exclusion Criteria: * Hypersensitivity to medications used for pain control (fentanyl, ropivacaine, morphine, acetaminophen, NSAIDs) * Cognitive impairment that affects using patient-controlled analgesia device or answering patient-reported questionnaires * Infection or anatomical abnormalities of the abdominal wall and skin that preclude catheterization for continuous wound infiltration * Contraindicated for intrathecal injection due to any coagulation disorder or continued use of anticoagulants * Have a major medical or psychiatric illness that would affect response to treatment * History of chronic pain, or chronic use of analgesics or psychiatric medications * Have severe liver or kidney disease * Anyone who are not appropriate for the study in the opinion of the investigators
Where it's running
-
Seoul National University Hospital
Seoul, Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Ho-jin Lee, M.D., PhD.
- Email: hjpainfree@snu.ac.kr
- Phone: +82-2-2072-0039
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine as add-on for refractory cancer pain in palliative care
This study tests whether adding dexmedetomidine helps improve pain control for adults with cancer in palliative care whose pain remains high despite opioids.
-
Two Ways to Help Pain After Breast Surgery: Education-Based Analgesia vs Standard Care
This trial tests whether teaching patients about pain management and using a multimodal pain plan improves pain control and recovery after breast surgery compared with standard care.
-
Virtual Reality Therapy to Improve Arthroplasty Outcomes
This pilot test checks whether using virtual reality during the perioperative period helps knee or hip replacement patients feel better about their care and recover more easily.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Analgesic effects of adding BiFeS block to adductor canal block after ACL reconstruction
This study tests whether adding a BiFeS block to the standard adductor canal block provides better pain relief after ACL reconstruction.
-
Low-Volume PENG Block With Dexamethasone After Hip Replacement
This trial tests whether a smaller PENG block with dexamethasone provides similar pain relief but preserves quadriceps strength after hip replacement, compared with the standard-volume PENG block.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.